Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
58 participants
OBSERVATIONAL
2025-07-01
2027-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study on Fetal Growth Restriction Complicated by Early Flowmetric Alterations
NCT06717555
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
NCT03398629
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161
Epigenetic Markers in Growth Restricted Human Pregnancies: a Case-controlled Study
NCT00510380
Prediction of Late Fetal Growth Restriction Using Cerebroplacental Ratio
NCT04640467
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with pregnancies affected by idiopathic fetal growth restriction
Women with normal pregnancies and normally growing foetus
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* dated pregnancy
Exclusion Criteria
* receive treatments such as aspirin, progestogen, low molecular weight heparin
* has pre-existing medical disorders such as autoimmune disease, hypertension, diabetes
* smoking
* suspected intrauterine infection
19 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Canselor Tuanku Muhriz
Kuala Lumpur, Kuala Lumpur, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JEP-2025-183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.